Enhanced Proinflammatory State and Autoimmune Activation: a Breakthrough to Understanding Chronic Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|4|575-584

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.4, 2014-02, pp. : 575-584

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibitors of AP-1 and NF-&kgr;B Mediated Transcriptional Activation: Therapeutic Potential in Autoimmune Diseases and Structural Diversity

By  

Current Medicinal Chemistry, Vol. 9, Iss. 2, 2002-01 ,pp. : 219-227

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics, Target Molecules, and Biological Anti-Rheumatic Drugs in Autoimmune/Chronic Inflammatory Rheumatic Diseases

By  

Current Pharmacogenomics, Vol. 4, Iss. 2, 2006-06 ,pp. : 105-111

Bentham Science Publishers

Access to resources Recommend Favorite

Proinflammatory Activities of Leptin in Non-Autoimmune Conditions

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 11, Iss. 4, 2012-08 ,pp. : 298-302

Bentham Science Publishers

Access to resources Recommend Favorite

Biologic therapies in autoimmune diseases

By Penn Henry  

Clinical Medicine, Vol. 6, Iss. 1, 2006-01 ,pp. : 105-108

Royal College Of Physicians

Access to resources Recommend Favorite

Biotherapy for Autoimmune Liver Diseases

By  

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 6, 2014-06 ,pp. : 510-515

Bentham Science Publishers

Access to resources Recommend Favorite